Montag & Caldwell LLC Lifted Its Holding in Edwards Lifesciences Corp (EW) by $134.00 Million

September 13, 2017 - By Marie Mckinney

Montag & Caldwell Llc increased its stake in Edwards Lifesciences Corp (EW) by 10690.4% based on its latest 2016Q4 regulatory filing with the SEC. Montag & Caldwell Llc bought 1.44 million shares as the company’s stock rose 25.80% with the market. The institutional investor held 1.45M shares of the industrial specialties company at the end of 2016Q4, valued at $136.27M, up from 13,478 at the end of the previous reported quarter. Montag & Caldwell Llc who had been investing in Edwards Lifesciences Corp for a number of months, seems to be bullish on the $23.60B market cap company. The stock decreased 2.54% or $2.91 during the last trading session, reaching $111.78. About 1.21M shares traded or 0.83% up from the average. Edwards Lifesciences Corp (NYSE:EW) has risen 15.41% since September 13, 2016 and is uptrending. It has underperformed by 1.29% the S&P500.

Montag & Caldwell Llc, which manages about $14.22 billion and $4.14 billion US Long portfolio, decreased its stake in Dollar Tree Stores (NASDAQ:DLTR) by 343,668 shares to 2.12 million shares, valued at $163.26 million in 2016Q4, according to the filing. It also reduced its holding in Bristol (NYSE:BMY) by 1.39M shares in the quarter, leaving it with 1.07 million shares, and cut its stake in Thermo Fisher Scientific (NYSE:TMO).

More notable recent Edwards Lifesciences Corp (NYSE:EW) news were published by: which released: “Edwards Lifesciences Stock To Remain Strong Ahead Of Robust Revenue And New …” on August 15, 2017, also with their article: “Why the Earnings Streak Will Continue for Edwards Lifesciences (EW)” published on September 12, 2017, published: “Here’s Why Investors Should Buy Edwards Lifesciences Now” on August 17, 2017. More interesting news about Edwards Lifesciences Corp (NYSE:EW) were released by: and their article: “Edwards Lifesciences To Present At The 12th Annual Wells Fargo Healthcare …” published on August 31, 2017 as well as‘s news article titled: “Scholtz & Company, Llc Buys Edwards Lifesciences Corp, Cotiviti Holdings Inc …” with publication date: August 14, 2017.

Edwards Lifesciences Corp (NYSE:EW) Ratings Coverage

Among 26 analysts covering Edwards Lifesciences Corp (NYSE:EW), 20 have Buy rating, 1 Sell and 5 Hold. Therefore 77% are positive. Edwards Lifesciences Corp had 76 analyst reports since July 30, 2015 according to SRatingsIntel. The rating was upgraded by SunTrust to “Buy” on Thursday, January 21. The firm has “Buy” rating given on Tuesday, June 27 by Canaccord Genuity. The stock of Edwards Lifesciences Corp (NYSE:EW) earned “Buy” rating by RBC Capital Markets on Friday, September 1. The rating was reinitiated by JMP Securities on Wednesday, January 6 with “Mkt Perform”. Barclays Capital maintained Edwards Lifesciences Corp (NYSE:EW) rating on Thursday, July 27. Barclays Capital has “Equal-Weight” rating and $120 target. Barclays Capital maintained the stock with “Equalweight” rating in Wednesday, July 27 report. Bank of America upgraded the shares of EW in report on Thursday, July 27 to “Buy” rating. The company was maintained on Wednesday, April 26 by Stifel Nicolaus. The company was maintained on Wednesday, February 3 by RBC Capital Markets. The rating was maintained by RBC Capital Markets with “Buy” on Tuesday, May 30.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.